Levemir Discontinuation: What You Need to Know
Novo Nordisk, a global healthcare company, has recently announced the discontinuation of Levemir, a long-acting insulin, in the United States. This significant development, announced in November 2023, is set to reshape the landscape for many relying on this medication. Key Points of the Announcement: Impact Period: Expected to commence in January 2024 and span through […]
Levemir Discontinuation: What You Need to Know Read More »
